Stay updated on Belantamab Mafodotin in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.

Latest updates to the Belantamab Mafodotin in Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a new revision entry 'Revision: v3.5.4' to the study record history and removed the previous 'Revision: v3.5.3' entry. The version history now reflects the latest revision of the record.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe web interface’s revision version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the underlying ClinicalTrials.gov record details.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded a new 'Study Status' entry to the record history and updated the latest version indicator to 10. The 2025-12-15 entry was removed from the history.SummaryDifference0.4%

- Check73 days agoChange DetectedRevision history updated: added version v3.5.0 and removed version v3.4.3.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded revision v3.4.3 to the history and removed revision v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Belantamab Mafodotin in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.